Loading clinical trials...
Loading clinical trials...
A Phase II, Randomized, Adaptive Design, Multicenter, Parallel Group, Placebo-Controlled, 58 Day, Dose-Ranging Study of ATI 7505 in Patients With Postprandial Distress Syndrome
Conditions
Interventions
Placebo
20 mg ATI 7505
+2 more
Locations
64
United States
Research Facility
Chino, California, United States
Research Facility
Fresno, California, United States
Research Facility
Los Angeles, California, United States
Research Facility
Los Angeles, California, United States
Research Facility
Mission Viejo, California, United States
Research Facility
San Carlos, California, United States
Start Date
February 1, 2008
Primary Completion Date
July 1, 2008
Completion Date
July 1, 2008
Last Updated
June 17, 2009
Lead Sponsor
Procter and Gamble
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions